228 related articles for article (PubMed ID: 8465818)
1. The familial risk of end-stage renal disease in African Americans.
Freedman BI; Spray BJ; Tuttle AB; Buckalew VM
Am J Kidney Dis; 1993 Apr; 21(4):387-93. PubMed ID: 8465818
[TBL] [Abstract][Full Text] [Related]
2. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus.
Freedman BI; Tuttle AB; Spray BJ
Am J Kidney Dis; 1995 May; 25(5):710-3. PubMed ID: 7747724
[TBL] [Abstract][Full Text] [Related]
3. Familial risk, age at onset, and cause of end-stage renal disease in white Americans.
Spray BJ; Atassi NG; Tuttle AB; Freedman BI
J Am Soc Nephrol; 1995 Apr; 5(10):1806-10. PubMed ID: 7787148
[TBL] [Abstract][Full Text] [Related]
4. Kidney disease in the first-degree relatives of African-Americans with hypertensive end-stage renal disease.
Bergman S; Key BO; Kirk KA; Warnock DG; Rostant SG
Am J Kidney Dis; 1996 Mar; 27(3):341-6. PubMed ID: 8604702
[TBL] [Abstract][Full Text] [Related]
5. Familial clustering of end-stage renal disease in blacks with lupus nephritis.
Freedman BI; Wilson CH; Spray BJ; Tuttle AB; Olorenshaw IM; Kammer GM
Am J Kidney Dis; 1997 May; 29(5):729-32. PubMed ID: 9159307
[TBL] [Abstract][Full Text] [Related]
6. Familial clustering of end-stage renal disease in Mississippi.
Butkus DE
J Miss State Med Assoc; 2002 Mar; 43(3):71-7. PubMed ID: 11944578
[TBL] [Abstract][Full Text] [Related]
7. Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans.
Freedman BI; Yu H; Spray BJ; Rich SS; Rothschild CB; Bowden DW
Kidney Int; 1997 Mar; 51(3):819-25. PubMed ID: 9067916
[TBL] [Abstract][Full Text] [Related]
8. Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis.
Zarif L; Covic A; Iyengar S; Sehgal AR; Sedor JR; Schelling JR
Nephrol Dial Transplant; 2000 Nov; 15(11):1801-7. PubMed ID: 11071968
[TBL] [Abstract][Full Text] [Related]
9. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy.
Freedman BI; Soucie JM; Stone SM; Pegram S
Am J Kidney Dis; 1999 Aug; 34(2):254-8. PubMed ID: 10430971
[TBL] [Abstract][Full Text] [Related]
10. Familial aggregation of renal disease in a population-based case-control study.
Lei HH; Perneger TV; Klag MJ; Whelton PK; Coresh J
J Am Soc Nephrol; 1998 Jul; 9(7):1270-6. PubMed ID: 9644638
[TBL] [Abstract][Full Text] [Related]
11. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
Freedman BI; Langefeld CD; Turner J; Núñez M; High KP; Spainhour M; Hicks PJ; Bowden DW; Reeves-Daniel AM; Murea M; Rocco MV; Divers J
Kidney Int; 2012 Oct; 82(7):805-11. PubMed ID: 22695330
[TBL] [Abstract][Full Text] [Related]
12. Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.
Malhotra R; Cavanaugh KL; Blot WJ; Ikizler TA; Lipworth L; Kabagambe EK
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1079-1087. PubMed ID: 27562875
[TBL] [Abstract][Full Text] [Related]
13. Racial differences in incidence, outcome, and quality of life for African-Americans on hemodialysis.
Owen WF
Blood Purif; 1996; 14(4):278-85. PubMed ID: 8873953
[TBL] [Abstract][Full Text] [Related]
14. Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study.
O'Dea DF; Murphy SW; Hefferton D; Parfrey PS
Am J Kidney Dis; 1998 Nov; 32(5):794-801. PubMed ID: 9820449
[TBL] [Abstract][Full Text] [Related]
15. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
[TBL] [Abstract][Full Text] [Related]
16. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.
Brancati FL; Whittle JC; Whelton PK; Seidler AJ; Klag MJ
JAMA; 1992 Dec; 268(21):3079-84. PubMed ID: 1433738
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of nitric oxide and endothelin in end-stage renal disease.
Freedman BI; Yu H; Anderson PJ; Roh BH; Rich SS; Bowden DW
Nephrol Dial Transplant; 2000 Nov; 15(11):1794-800. PubMed ID: 11071967
[TBL] [Abstract][Full Text] [Related]
18. Family history of end-stage renal disease among hemodialyzed patients in Poland.
Gumprecht J; Zychma MJ; Moczulski DK; Gosek K; Grzeszczak W
J Nephrol; 2003; 16(4):511-5. PubMed ID: 14696752
[TBL] [Abstract][Full Text] [Related]
19. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.
Freedman BI; Hicks PJ; Bostrom MA; Cunningham ME; Liu Y; Divers J; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
Kidney Int; 2009 Apr; 75(7):736-45. PubMed ID: 19177153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
